{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:27:30Z","timestamp":1768012050724,"version":"3.49.0"},"reference-count":40,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,4]]},"abstract":"<jats:p>Cirrhosis is the dominant cause of portal hypertension globally but may be overshadowed by hepatosplenic schistosomiasis (HSS) in the tropics. In Zambia, schistosomiasis seroprevalence can reach 88% in endemic areas. Bacterial translocation (BT) drives portal hypertension in cirrhosis contributing to mortality but remains unexplored in HSS. Rifaximin, a non-absorbable antibiotic may reduce BT. We aimed to explore the influence of rifaximin on BT, inflammation, and fibrosis in HSS. In this phase II open-label trial (ISRCTN67590499), 186 patients with HSS in Zambia were evaluated and 85 were randomized to standard care with or without rifaximin for 42 days. Changes in markers of inflammation, BT, and fibrosis were the primary outcomes. BT was measured using plasma 16S rRNA, lipopolysaccharide-binding protein, and lipopolysaccharide, whereas hyaluronan was used to measure fibrosis. Tumor necrosis factor receptor 1 (TNFR1) and soluble cluster of differentiation 14 (sCD14) assessed inflammation. 16S rRNA reduced from baseline (median 146 copies\/\u00b5L, interquartile range [IQR] 9, 537) to day 42 in the rifaximin group (median 63 copies\/\u00b5L, IQR 12, 196), <jats:italic>P<\/jats:italic> &lt; 0.01. The rise in sCD14 was lower (<jats:italic>P<\/jats:italic> &lt; 0.01) in the rifaximin group (median rise 122 ng\/mL, IQR-184, 783) than in the non-rifaximin group (median rise 832 ng\/mL, IQR 530, 967). TNFR1 decreased (<jats:italic>P<\/jats:italic> &lt; 0.01) in the rifaximin group (median -39 ng\/mL IQR-306, 563) but increased in the non-rifaximin group (median 166 ng\/mL, IQR 3, 337). Other markers remained unaffected. Rifaximin led to a reduction of inflammatory markers and bacterial 16S rRNA which may implicate BT in the inflammation in HSS.<\/jats:p>","DOI":"10.4269\/ajtmh.17-0637","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T07:00:34Z","timestamp":1518505234000},"page":"1152-1158","source":"Crossref","is-referenced-by-count":4,"title":["Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial"],"prefix":"10.4269","volume":"98","author":[{"given":"Edford","family":"Sinkala","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia;"},{"name":"Department of Internal Medicine, Tropical Gastroenterology & Nutritional Group, University of Zambia, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanekwa","family":"Zyambo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tropical Gastroenterology & Nutritional Group, University of Zambia, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Besa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tropical Gastroenterology & Nutritional Group, University of Zambia, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kaonga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia;"},{"name":"Department of Internal Medicine, Tropical Gastroenterology & Nutritional Group, University of Zambia, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bright","family":"Nsokolo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia;"},{"name":"Department of Internal Medicine, Tropical Gastroenterology & Nutritional Group, University of Zambia, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violet","family":"Kayamba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia;"},{"name":"Department of Internal Medicine, Tropical Gastroenterology & Nutritional Group, University of Zambia, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Vinikoor","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama;"},{"name":"Centre for Infectious Disease Research in Zambia, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabison","family":"Zulu","sequence":"additional","affiliation":[{"name":"Paediatric Centre of Excellence Laboratory, University Teaching Hospital, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bwalya","sequence":"additional","affiliation":[{"name":"Paediatric Centre of Excellence Laboratory, University Teaching Hospital, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham R.","family":"Foster","sequence":"additional","affiliation":[{"name":"Blizard Institute, Barts & The London School of Medicine, Queen Mary University of London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia;"},{"name":"Department of Internal Medicine, Tropical Gastroenterology & Nutritional Group, University of Zambia, Lusaka, Zambia;"},{"name":"Paediatric Centre of Excellence Laboratory, University Teaching Hospital, Lusaka, Zambia;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","series-title":"J Clin Transl Hepatol","first-page":"212","article-title":"Review article hepatobiliary schistosomiasis","volume":"2","author":"Shaker","year":"2014"},{"key":"b2","series-title":"Liver Int","first-page":"145","article-title":"Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis","volume":"36","author":"Sinkala","year":"2015"},{"key":"b3","series-title":"Khartoum Med J","first-page":"385","article-title":"The natural history of bleeding oesophageal varices in patients with schistosomal portal hypertension","volume":"3","author":"Ibrahim","year":"2010"},{"key":"b4","series-title":"J Clin Exp Hepatol","first-page":"94","article-title":"Noncirrhotic portal hypertension","volume":"1","author":"Rajekar","year":"2011"},{"key":"b5","series-title":"East Afr Med J","first-page":"480","article-title":"Hepatosplenic schistosomiasis: a review","volume":"81","author":"Kibiki","year":"2004"},{"key":"b6","series-title":"Med J Zambia","first-page":"1","article-title":"Schistosomiasis disease burden in Zambian children: time for affirmative action is now","volume":"36","author":"Chipeta","year":"2009"},{"key":"b7","series-title":"Am J Trop Med Hyg","first-page":"965","article-title":"High Schistosoma mansoni disease burden in a rural district of western Zambia","volume":"91","author":"Mutengo","year":"2014"},{"key":"b8","series-title":"BMC Res Notes","first-page":"344","article-title":"Prevalence of schistosome antibodies with hepatosplenic signs and symptoms among patients from Kaoma, western province, Zambia","volume":"6","author":"Payne","year":"2013"},{"key":"b9","series-title":"Liver Int","first-page":"31","article-title":"Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications","volume":"33","author":"Bellot","year":"2013"},{"key":"b10","series-title":"Aliment Pharmacol Ther","first-page":"992","article-title":"Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis","volume":"29","author":"Vlachogiannakos","year":"2009"},{"key":"b11","series-title":"J Gastroenterol Hepatol","first-page":"464","article-title":"Bacterial translocation: overview of mechanisms and clinical impact","volume":"22","author":"Balzan","year":"2007"},{"key":"b12","series-title":"J Clin Invest","first-page":"1223","article-title":"Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility","volume":"104","author":"Wiest","year":"1999"},{"key":"b13","series-title":"Chin J Hepatol","first-page":"796","article-title":"Bacterial translocation and its consequences in patients with liver cirrhosis","volume":"14","author":"Gou","year":"2006"},{"key":"b14","series-title":"Hepatology","first-page":"2044","article-title":"Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis","volume":"52","author":"Bellot","year":"2010"},{"key":"b15","series-title":"World J Hepatol","first-page":"425","article-title":"Gut-liver axis in liver cirrhosis: how to manage leaky gut and endotoxemia","volume":"7","author":"Fukui","year":"2015"},{"key":"b16","series-title":"Hepatology","first-page":"1107","article-title":"Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis","volume":"31","author":"Nagasue","year":"2000"},{"key":"b17","series-title":"Aliment Pharmacol Ther","first-page":"509","article-title":"Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding\u2014an updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011"},{"key":"b18","series-title":"World J Hepatol","first-page":"2264","article-title":"Markers of bacterial translocation in end-stage liver disease","volume":"7","author":"Koutsounas","year":"2015"},{"key":"b19","series-title":"Am J Trop Med Hyg","first-page":"321","article-title":"Human schistosomiasis is associated with endotoxemia and toll-like receptor 2- and 4-bearing B cells","volume":"84","author":"Onguru","year":"2011"},{"key":"b20","series-title":"Surg Infect (Larchmt)","first-page":"197","article-title":"Gut bacterial translocation and postoperative infections: a prospective study in schistosomotic patients","volume":"6","author":"Ferraz","year":"2005"},{"key":"b21","series-title":"PLoS One","first-page":"e93909","article-title":"Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites","volume":"9","author":"Lutz","year":"2014"},{"key":"b22","series-title":"ISRN Oncol","first-page":"371854","article-title":"Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy","volume":"2013","author":"Bremer","year":"2013"},{"key":"b23","series-title":"N Engl J Med","first-page":"1071","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Nathan","year":"2010"},{"key":"b24","series-title":"Antimicrob Agents Chemother","first-page":"1179","article-title":"Systemic pharmacokinetics of rifaximin in volunteers with shigellosis","volume":"52","author":"Taylor","year":"2008"},{"key":"b25","series-title":"Gastroenterol","first-page":"484","article-title":"Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats","volume":"146","author":"Xu","year":"2014"},{"key":"b26","series-title":"Clin Med Insights Gastroenterol","first-page":"31","article-title":"Rifaximin therapy of irritable bowel syndrome","volume":"5","author":"Koo","year":"2012"},{"key":"b27","series-title":"Aliment Pharmacol Ther","first-page":"39","article-title":"Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis","volume":"41","author":"Bajaj","year":"2015"},{"key":"b28","series-title":"Immunology","first-page":"174","article-title":"Soluble CD14 is essential for lipopolysaccharide-dependent activation of human intestinal mast cells from macroscopically normal as well as Crohn\u2019s disease tissue","volume":"143","author":"Brenner","year":"2014"},{"key":"b29","series-title":"Clin Microbiol Rev","first-page":"2","article-title":"Microbial translocation in the pathogenesis of HIV infection and AIDS","volume":"26","author":"Marchetti","year":"2013"},{"key":"b30","series-title":"J Infect Dis","first-page":"343","article-title":"Inflammatory markers related to microbial translocation among HIV-infected pregnant women: a risk factor of preterm delivery","volume":"213","author":"L\u00f3pez","year":"2015"},{"key":"b31","series-title":"J Infect Dis","first-page":"19","article-title":"Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection","volume":"211","author":"Dinh","year":"2015"},{"key":"b32","series-title":"J Lipid Res","first-page":"1943","article-title":"Apolipoprotein CI enhances the biological response to LPS via the CD14\/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix","volume":"51","author":"Berb\u00e9e","year":"2010"},{"key":"b33","series-title":"Hepatology","first-page":"319","article-title":"Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis","volume":"54","author":"Tarrats","year":"2011"},{"key":"b34","series-title":"PLoS One","first-page":"1","article-title":"Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity","volume":"8","author":"Gonzalez-Quintela","year":"2013"},{"key":"b35","series-title":"J Gerontol A Biol Sci Med Sci","first-page":"1212","article-title":"Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults","volume":"67","author":"Stehle","year":"2012"},{"key":"b36","series-title":"Clin Diagn Lab Immunol","first-page":"113","article-title":"The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome","volume":"4","author":"Myc","year":"1997"},{"key":"b37","series-title":"Mem Inst Oswaldo Cruz, Rio","first-page":"471","article-title":"Serum hyaluronan and collagen IV as non-invasive markers of liver fibrosis in patients from an endemic area for Schistosomiasis mansoni: a field-based study in Brazil","volume":"105","author":"Marinho","year":"2010"},{"key":"b38","series-title":"J Hepatol","first-page":"893","article-title":"Intestinal decontamination inhibits TLR4 dependent fibronectin mediated crosstalk between stellate cells and endothelial cells in liver fibrosis in mice","volume":"56","author":"Zhu","year":"2012"},{"key":"b39","series-title":"Rev Bras Hematol Hemoter","first-page":"332","article-title":"Relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis","volume":"35","author":"Arthur","year":"2013"},{"key":"b40","series-title":"World J Gastroenterol","first-page":"5982","article-title":"Benefit of combination \u03b2-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis","volume":"16","author":"Funakoshi","year":"2010"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/98\/4\/article-p1152.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/98\/4\/article-p1152.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/98\/4\/article-p1152.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T15:34:12Z","timestamp":1722440052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/98\/4\/article-p1152.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":40,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.17-0637","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]}}}